IP Library Patent Application 12559276
Patent Application
App. No. 12/559,276

METHODS AND COMPOSITIONS RELATING TO POLYPEPTIDES WITH RNASE III DOMAINS THAT MEDIATE RNA INTERFERENCE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/559,276
Abstract

The present invention concerns methods and compositions involving RNase III and polypeptides containing RNase III domains to generate RNA capable of triggering RNA-mediated interference (RNAi) in a cell. In some embodiments, the RNase III is from a prokaryote. RNase III activity will cleave a double-stranded RNA molecule into short RNA molecules that may trigger or mediate RNAi (siRNA). Compositions of the invention include kits that include an RNase III domain-containing polypeptide. The present invention further concerns methods using polypeptides with RNase III activity for generating RNA molecules that effect RNAi, including the generation of a number of RNA molecules to the same target.

Claims (30)

1 . A method of reducing expression of a target gene in a cell comprising:

a) incubating a dsRNA corresponding to part of the target gene with an effective amount of a composition comprising a polypeptide comprising an RNase III domain, under conditions to allow RNase III to cleave the dsRNA into siRNA; and

b) transfecting the siRNA into the cell.

2 . The method of claim 1 , wherein the polypeptide is chimeric.

3 . The method of claim 1 , further comprising isolating the siRNA molecules prior to transfection.

4 . The method of claim 1 , wherein the dsRNA is 25 to 10,000 bases or basepairs in length.

5 . The method of claim 4 , wherein the dsRNA is 50 to 1,000 bases or basepairs in length.

6 . The method of claim 5 wherein the dsRNA is 100 to 200 bases or basepairs in length.

7 . The method of claim 1 , wherein the dsRNA is obtained by transcribing each strand of the dsRNA from one or more cDNA encoding the strands in vitro; isolating the strands; and, incubating the strands under conditions that allow the strands to hybridize to their complementary strands.

8 . The method of claim 1 , wherein dsRNA for at least a second targeted gene is included.

9 . A method for achieving RNA interference of a target gene in a cell using one or more siRNA molecules comprising:

a) generating at least one double-stranded DNA template corresponding to part of the target gene, wherein the DNA template comprises an SP6, T3, or T7 promoter on at least one strand;

b) transcribing the template, wherein either i) a single RNA strand with a complementarity region, or ii) first and second complementary RNA strands is/are created;

c) hybridizing either the single complementary RNA strand or first and second complementary RNA strands to create a dsRNA molecule corresponding to the target gene;

d) incubating the dsRNA molecule with a polypeptide comprising an RNase III domain, under conditions to allow cleavage of the dsRNA into at least two siRNA; and

e) transfecting at least one siRNA into the cell.

10 . The method of claim 9 , wherein the polypeptide is RNase III.

11 . The method of claim 9 , wherein the polypeptide is chimeric.

12 . The method of claim 9 , wherein multiple siRNA molecules are transfected into the cell.

13 . A kit for generating siRNA molecules comprising:

a) recombinant, prokaryotic RNase III;

b) RNase III buffer; and

c) a control nucleic acid.

14 . A method for generating siRNA that can reduce expression of a target gene comprising incubating a dsRNA corresponding to part of the target gene with an effective amount of a composition comprising a polypeptide comprising an RNase III domain, under conditions to allow RNase III to cleave the dsRNA into siRNA.

15 . The method of claim 14 , wherein the polypeptide is chimeric.

16 . The method of claim 14 , further comprising isolating the siRNA molecules.

17 . The method of claim 14 , wherein the dsRNA is 25 to 10,000 bases or basepairs in length.

18 . The method of claim 17 , wherein the dsRNA is 50 to 1,000 bases or basepairs in length.

19 . The method of claim 18 , wherein the dsRNA is 100 to 200 bases or basepairs in length.

20 . The method of claim 14 , wherein dsRNA for at least a second targeted gene is included.